Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Line Probe Assay Evaluation Study

NCT: NCT02984579 · COMPLETED

NCT IDNCT02984579
StatusCOMPLETED
Start Date2015-03
Completion2016-01
SponsorFoundation for Innovative New Diagnostics, Switzerland (OTHER)
First posted
Last updated

Brief Summary

This is a multi-center, blinded study to determine the performance of the YD Diagnostic Corporation (YD) REBA MTB-MDR® and Hain Genotype MTBDRplus V2 kit in a total of 600 clinical isolates and 900 residual sputum samples from patients with symptoms of pulmonary TB (PTB) and at risk of drug resistance. All testing was done on stored, de-identified leftover samples. The study involved three World Health Organization (WHO) Supranational Reference Laboratories with well-characterized strain collections and access to sputum samples with significant rates of drug resistance.

Frequently Asked Questions

What is Line Probe Assay Evaluation Study?

Line Probe Assay Evaluation Study is a clinical trial registered under NCT02984579. Current status: COMPLETED.

What is the status of NCT02984579?

The current status of NCT02984579 (Line Probe Assay Evaluation Study) is: COMPLETED.

When did Line Probe Assay Evaluation Study start?

Line Probe Assay Evaluation Study started on 2015-03.

Related Devices

K241946PeritX™ 1L Drainage Kit (90-1010); PeritX™ 2L Drainage Kit (90-2010); PeritX™ Peritoneal Catheter Kit (50-9000C); PeritX™ Peritoneal Catheter and Starter Kit (50-9900C); PeritX™ Peritoneal Catheter Mini Kit (50-9050A); PleurX™ Low Profile Catheter Mini Kit (50-8050); Valve Cap (50-7235A); PeritX™ Valve Kit (50-7272); Catheter Access Kit (50-7280A); Lockable Drainage Line (50-7245A); Lockable Drainage Line Kit (50-7265A); PleurX™ Supplemental Insertion Kit (50-7262); Procedure Pack (50-Bard Peripheral Vascular, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑